Skip to main content

Find Clinical Trials

Home
Conditions
Glomerulonephritis, IGA

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

203 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Recruiting

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

NCT04858724

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

NCT07146906

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Colorado Kidney Care Nephrology Denver, Colorado, United States

American Clinical Trials Acworth, Georgia, United States

Univ Of Iowa Hospitals And Clinics Iowa City, Iowa, United States

Inter Med Consultants Edina, Minnesota, United States

View all 29 locations

View Trial Details

Recruiting

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

NCT07614477

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

Tianjin Medical University General Hospital Tianjin, Hebei, China

View Trial Details

Recruiting

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

NCT06419205

Conditions: Autoimmune Diseases, C3 (Complement Component 3) Glomerulopathy, Complement Component 3 Deficiency, Autosomal Recessive, +16 more
Locations: Investigator Site #1 Lawrenceville, Georgia, United States

Investigator Site #2 São Paulo, Brazil

View Trial Details

Recruiting

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

NCT07203404

Conditions: ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +29 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

NCT06466135

Conditions: Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +18 more
Locations: Academic Medical Research Institute Los Angeles, California, United States

Colorado Kidney and Vascular Care Denver, Colorado, United States

D & H Tamarac Research Center Tamarac, Florida, United States

Fides Clinical Research Atlanta, Georgia, United States

View all 50 locations

View Trial Details

Recruiting

Study of Ravulizumab in Pediatric Participants With Primary IgAN

NCT07024563

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +36 more
Locations: Research Site Palo Alto, California, United States

Research Site Aurora, Colorado, United States

Research Site Beijing, China

Research Site Shanghai, China

View all 15 locations

View Trial Details

Recruiting

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

NCT07582133

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

NCT07010250

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +31 more
Locations: Georges-Pompidou European Hospital, AP-HP Paris, France

View Trial Details

Recruiting

Atacicept in Multiple Glomerular Diseases

NCT06983028

Conditions: Autoimmune Diseases, FSGS, Female Urogenital Diseases, +15 more
Locations: Vera Therapeutics Brisbane, California, United States

View Trial Details